Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Genetic ancestry, serum interferon-α activity, and autoantibodies in systemic lupus erythematosus.

Ko K, Franek BS, Marion M, Kaufman KM, Langefeld CD, Harley JB, Niewold TB.

J Rheumatol. 2012 Jun;39(6):1238-40. doi: 10.3899/jrheum.111467. Epub 2012 Apr 15.

2.

Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus.

Weckerle CE, Franek BS, Kelly JA, Kumabe M, Mikolaitis RA, Green SL, Utset TO, Jolly M, James JA, Harley JB, Niewold TB.

Arthritis Rheum. 2011 Apr;63(4):1044-53. doi: 10.1002/art.30187.

3.

IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.

Niewold TB, Kelly JA, Kariuki SN, Franek BS, Kumar AA, Kaufman KM, Thomas K, Walker D, Kamp S, Frost JM, Wong AK, Merrill JT, Alarcón-Riquelme ME, Tikly M, Ramsey-Goldman R, Reveille JD, Petri MA, Edberg JC, Kimberly RP, Alarcón GS, Kamen DL, Gilkeson GS, Vyse TJ, James JA, Gaffney PM, Moser KL, Crow MK, Harley JB.

Ann Rheum Dis. 2012 Mar;71(3):463-8. doi: 10.1136/annrheumdis-2011-200463. Epub 2011 Nov 16.

4.

Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.

Salloum R, Franek BS, Kariuki SN, Rhee L, Mikolaitis RA, Jolly M, Utset TO, Niewold TB.

Arthritis Rheum. 2010 Feb;62(2):553-61. doi: 10.1002/art.27182.

5.

The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes.

Agik S, Franek BS, Kumar AA, Kumabe M, Utset TO, Mikolaitis RA, Jolly M, Niewold TB.

J Rheumatol. 2012 Jan;39(1):73-8. doi: 10.3899/jrheum.110590. Epub 2011 Nov 1.

6.

Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus.

Weckerle CE, Mangale D, Franek BS, Kelly JA, Kumabe M, James JA, Moser KL, Harley JB, Niewold TB.

Arthritis Rheum. 2012 Sep;64(9):2947-52. doi: 10.1002/art.34483.

7.

Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.

Niewold TB, Kelly JA, Flesch MH, Espinoza LR, Harley JB, Crow MK.

Arthritis Rheum. 2008 Aug;58(8):2481-7. doi: 10.1002/art.23613.

8.

High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.

Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK.

Genes Immun. 2007 Sep;8(6):492-502. Epub 2007 Jun 21.

9.

Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.

Jolly M, Francis S, Aggarwal R, Mikolaitis RA, Niewold TB, Chubinskaya S, Block JA, Scanzello C, Sequeira W.

Lupus. 2014 Aug;23(9):881-8. doi: 10.1177/0961203314530793. Epub 2014 Apr 30.

PMID:
24786785
10.

Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.

Chauhan SK, Singh VV, Rai R, Rai M, Rai G.

J Clin Immunol. 2013 Jul;33(5):954-64. doi: 10.1007/s10875-013-9887-0. Epub 2013 Apr 7.

PMID:
23564191
11.

Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.

Munroe ME, Lu R, Zhao YD, Fife DA, Robertson JM, Guthridge JM, Niewold TB, Tsokos GC, Keith MP, Harley JB, James JA.

Ann Rheum Dis. 2016 Nov;75(11):2014-2021. doi: 10.1136/annrheumdis-2015-208140. Epub 2016 Jan 25.

PMID:
27088255
12.

Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.

Bruner BF, Guthridge JM, Lu R, Vidal G, Kelly JA, Robertson JM, Kamen DL, Gilkeson GS, Neas BR, Reichlin M, Scofield RH, Harley JB, James JA.

Arthritis Rheum. 2012 Nov;64(11):3677-86. doi: 10.1002/art.34651.

13.

Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus.

Postal M, Sinicato NA, Peliçari KO, Marini R, Lavras Costallat LT, Appenzeller S.

Clinics (Sao Paulo). 2012;67(2):157-62.

14.

Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs.

Lyn-Cook BD, Xie C, Oates J, Treadwell E, Word B, Hammons G, Wiley K.

Mol Immunol. 2014 Sep;61(1):38-43. doi: 10.1016/j.molimm.2014.05.001. Epub 2014 May 24.

PMID:
24865418
15.

Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population.

Mu R, Sun XY, Lim LT, Xu CH, Dai CX, Su Y, Jia RL, Li ZG.

Chin Med J (Engl). 2012 Aug;125(16):2873-7.

PMID:
22932083
16.

Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients.

Kariuki SN, Franek BS, Mikolaitis RA, Utset TO, Jolly M, Skol AD, Niewold TB.

J Biomed Biotechnol. 2010;2010:826434. doi: 10.1155/2010/826434. Epub 2010 Jul 4.

17.

Association of anti-nucleoprotein autoantibodies with upregulation of Type I interferon-inducible gene transcripts and dendritic cell maturation in systemic lupus erythematosus.

Zhuang H, Narain S, Sobel E, Lee PY, Nacionales DC, Kelly KM, Richards HB, Segal M, Stewart C, Satoh M, Reeves WH.

Clin Immunol. 2005 Dec;117(3):238-50. Epub 2005 Aug 25.

PMID:
16126005
18.

Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus.

Hanly JG, Su L, Farewell V, Fritzler MJ.

J Immunol Methods. 2010 Jun 30;358(1-2):75-80. doi: 10.1016/j.jim.2010.04.005. Epub 2010 May 9.

PMID:
20438730
19.

Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients.

Hermansen ML, Hummelshøj L, Lundsgaard D, Hornum L, Keller P, Fleckner J, Fox B, Poulsen LK, Jacobsen S.

Lupus. 2012 Sep;21(10):1098-104. doi: 10.1177/0961203312447668. Epub 2012 May 10.

PMID:
22577117
20.

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.

Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H, Rönnblom L.

Lupus. 2000;9(9):664-71.

PMID:
11199920

Supplemental Content

Support Center